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aureus colonization in pregnant women and newborns (NB) and the factors associated with nasal
colonization. For NB, 4 sites were evaluated: nares, oropharynx, perineum, and umbilical stump (birth,
third day, and weekly). For pregnant women, 4 sites during labor: anterior nares, anus, perineum, and
oropharynx. Nasally colonized patients were compared with colonized only extranasally. Colonization was
53% of 392 pregnant women (methicillin-resistant S. aureus [MRSA]: 4%) and 47% of 382 NB (MRSA: 9%). For
newborn patients, the best body site was the umbilical stump (methicillin-susceptible S. aureus [MSSA]: 64%;
MRSA: 68%) and the combination of nares + umbilical (MSSA: 86%; MRSA: 91%). Among pregnant women,
the best body site was the anterior nares (MSSA: 59%; MRSA: 67%) and the combination of nares +
oropharynx (MSSA: 83%; MRSA: 80%). A smaller number of household members were associated with MRSA
carriage in pregnant women (2.2 ± 0.6 versus 3.6 ± 1.8; P = 0.04). In conclusion, multiple culture sites are
needed. Control programs based on surveillance cultures may be compromised.undação de Amparo a Pesquisa
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Surveillance cultures are one of the strategies used to control
Staphylococcus aureus infections, especially methicillin-resistant
S. aureus (MRSA). These cultures are used to determine asymptomatic
carriers and prevent the spread of the organism to other patients by
putting carriers under isolation precautions. Also, some authors
demonstrated that decolonization of carriers can reduce the risk of
staphylococcal infections under certain conditions (Simor, 2011). The
most commonly cultured body sites are the anterior nares, but the
challenge remains to determine whether routine culturing of other
body sites is necessary. The objectives of this study were to evaluatethe performance of surveillance cultures at various body sites in
determining colonization by S. aureus in pregnant women and their
newborns (NB), and to determine the factors associated with nasal
colonization, in comparison with other sites.2. Material and methods
Hospital das Clínicas is a tertiary care hospital afﬁliated with the
University of São Paulo, Brazil. Its nursery and neonatal intensive care
unit admit only NB born in the hospital, mostly fromhigh-risk pregnan-
cies. These units together receive approximately 170 NB each month.
This study occurred from February 2009 through January 2010 and
involved surveillance cultures of pregnantwomen and their NB. It was
approved by the Ethics in Research Committee of the hospital.
Surveillance cultures were collected by swabbing anatomical sites.
Newborn samples were collected from 4 sites: anterior nares,
oropharynx, perineum, and umbilical stump. Samples from pregnant
women were collected from 4 sites at birth: anterior nares, anus,
perineum, and oropharynx. During follow-up, cultures from mothers
were obtained from the nares and oropharynx.
Table 1
General characteristics of the 392 pregnant women who delivered at Hospital das
Clínicas, University of São Paulo, Brazil, and who were evaluated for colonization by
S. aureus (February 2009–January 2010).
Characteristics Mean (SD) Median Range
Age (years) (data available for 391) 30.5 (6.8) 30 15–48
Number of pregnancies 2.6 (1.6) 2 1–9
Number of previous deliveries 1.3 (1.3) 1 0–7
Number of previous abortions 0.4 (0.8) 0 0–5
Days of hospitalization
(admission to delivery)
3.0 (7.0) 0 0–51
Formal education (data available for 383) Frequency
b5 years 23 (6%)
5 to 9 years 102 (27%)
10 to 12 years 218 (57%)
N12 years 40 (10%)
Underlying conditions
Urinary tract infection treated during pregnancy 108 (28%)
Smoker 91 (23%)
Surgery during last year 46 (12%)
Smoked during pregnancy 40 (10%)
Underlying diseases 297 (76%)
Chronic hypertension 89 (23%)
Chronic rhino-sinusitis 77 (20%)
Gestational hypertension 58 (15%)
Gestational diabetes mellitus 44 (11%)
Heart diseases 34 (9%)
Diabetes mellitus (not gestational) 23 (6%)
Vascular diseases 22 (6%)
HIV infection 6 (1.5%)
Other 152 (39%)
Use of medication
Antimicrobial drug during pregnancy 130 (33%)
Corticosteroids during pregnancy 20 (5%)
Delivery type (data available for 388)
Cesarean section 285 (74%)
Normal 79 (20%)
Forceps 24 (6%)
Prenatal follow-up (data available for 391)
In our hospital 290 (74%)
In another healthcare institution 65 (17%)
In our hospital and another one 33 (8%)
Not done 3 (1%)
Mean (SD) Median Range
Number of prenatal doctor visits
(data available for 384)
9.1 (3.8) 9 0–23
Gestational age on ﬁrst prenatal
visit (weeks) (data available for 384)
14.2 (7.2) 13 0–37
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in the delivery room or on arrival to the nursery—and, after 3 days,
immediately before discharge from the hospital. NB who remained in
care for longer than 3 days had cultures collected weekly until
hospital discharge or until the fourth week, whichever occurred ﬁrst.
The surveillance cultures from pregnant women were collected at
birth, in the delivery room, and, if possible, during their NB's hospital
stay (same days as the NB), if they were breastfeeding.
Clinical data were obtained from the patients' records and by
interviewing the mothers.
A patient was considered to be colonized if there was at least 1
positive surveillance culture for MRSA or methicillin-susceptible
S. aureus (MSSA) at any body site. Only the ﬁrst occasion when a
positive culture occurred was considered for each patient. Patients
who did not have a positive culture during their entire hospital stay
were considered “not colonized” by S. aureus.
For NB, positive results at birth were disregarded as they were
considered to be contamination. Individuals colonized with both
MRSA and MSSA were also excluded from this study. We did not
monitor each patient for the development of infection.
2.1. Microbiological methods
Sterile swabs were used to culture body sites, transported in Stuart
medium, added to brain heart infusionmedium, incubated at 35 °C for
24 h (Murray et al., 1999) for sample enrichment, plated in mannitol
salt agar, and then incubated again at 35 °C for 48 h. S. aureus ferment
mannitol and formed characteristic colonies suggestive of this
microorganism (Singh et al., 2003).
After incubation, the characteristic colonies were plated and
isolated in sheep blood agar 5% and incubated again at 35 °C for
24 h. Colonies suspected to be S. aureuswere phenotypically identiﬁed
by Gram stain, catalase reaction, and DNAse tests (Mir et al., 1998).
S. aureus isolates were submitted to an oxacillin resistance screening
test, using Mueller-Hinton agar with NaCl 4% and oxacillin 6 μg/mL,
according to CLSI (2010) guidelines. Quality control was performed
using S. aureus ATCC25923.
Conﬁrmation was performed by detection of the mecA and coa
genes, using a set of 4 multiplex polymerase chain reaction (PCR)
primers described elsewhere (Kearns et al., 1999). Ampliﬁcation
was performed using thermocycler PTC200 (MJ Research, Massachu-
setts, USA).
As positive and negative controls for mecA, S. aureus NCTC10442
(Katayama et al., 2000) and ATCC29213 were used, respectively. As
positive and negative controls for coa, S. aureus NCTC10442 and
Staphylococcus epidermidis were used, respectively. In all reactions,
sterile distilled deionized water was used as negative control.
After electrophoresis, DNA was colored with SYBR Safe® DNA gel
stain (Invitrogen, New York, USA) and visualized and photographed
under ultraviolet transillumination.
2.2. Data analysis
A database was made using the software Microsoft Ofﬁce Excel
2007 (Microsoft, Santa Rosa, CA, USA) and Epi Data (The Epi Data
Association, Odense, Denmark). Analyses were performed using the
software Epi Info™ version 3.5.3 (CDC, Atlanta, GA, USA).
A descriptive analysis of the characteristics of the patients
colonized with S. aureus was performed, determining frequency for
categorical variables and, for continuous variables, mean, standard
deviation, median, and range.
The patients colonized at the anterior nares were compared with
patients colonized at other sites except the nares, to determine the
factors associated with nasal colonization. Relative risk and 95%
conﬁdence intervals were determined for dichotomous variables, and
a variable was considered signiﬁcantly associated with nasalcolonization if the conﬁdence interval did not include 1.0. For
continuous variables, we used analysis of variance. Statistical
signiﬁcance was calculated using χ2 analysis, and if values were
≤5, Fisher test was preferred. Statistical signiﬁcance was considered
if P b 0.05.
As we believed that there was no adequate gold standard, we
decided not to calculate sensitivity and speciﬁcity. Positivity was
calculated using as numerator the number of individuals colonized
at each body site and, as denominator, the total number of colonized
patients with the microorganism. We evaluated separately mothers
and NB and determined the positivity rates for S. aureus, MSSA,
and MRSA.3. Results
We initially evaluated 404 pregnant women and 423 NB, with a
total of 6149 swabs collected yielding 1631 S. aureus isolates.
We excluded 2 pregnant women who did not give consent and 2
from whom we could only culture 3 of the 4 body sites. We also
excluded 8 who were colonized simultaneously by MRSA and MSSA.
Thus 392 pregnant women were included in the study. The clinical
characteristics of this population can be seen in Table 1.
Table 2
General characteristics of the 382 neonates born at Hospital das Clínicas, University of
São Paulo, Brazil, who were evaluated for colonization by S. aureus (February 2009–
January 2010).
Characteristics Frequency
Male sex 189 (49%)
Apgar on ﬁrst minute
8 to 10 344 (90%)
4 to 7 32 (8%)
0 to 3 6 (2%)
Apgar on ﬁfth minute
8 to 10 374 (98%)
4 to 7 7 (2%)
0 to 3 1 (b1%)
Birth weight (g)
N2501 358 (94%)
1501 to 2500 9 (2%)
1001 to 1500 10 (3%)
b1000 5 (1%)
Gestational age at birth (weeks)
b37 82 (22%)
37 to 41 298 (78%)
N42 2 (b1%)
Amniotic ﬂuid at birth
Clear 355 (93%)
Meconium and/or blood 27 (7%)
Used antimicrobial drugs during hospitalization 39 (10%)
Used a peripheral venous catheter 57 (15%)
Received parenteral nutrition 30 (8%)
Used a central venous catheter 30 (8%)
Submitted to mechanical ventilation 18 (5%)
Submitted to noninvasive ventilation 16 (4%)
Underwent dialysis 9 (2%)
Underwent surgery 7 (2%)
Received blood transfusion 6 (2%)
Discharged on the 3rd day 300 (79%)
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sampling, 5 because third-day samples were not collected, and 13
who had not collected swabs at all sites at birth because of difﬁculties
in sampling. We also excluded 20 NB who were colonized simulta-
neously by MRSA and MSSA. Thus 382 NB were included in the study.
The characteristics of this population can be seen in Table 2.
Among the pregnant women, the prevalence of S. aureus
colonization was 53% (206), that of MSSA colonization was 49%
(191), and that of MRSA colonization was 4% (15). The prevalence of
S. aureus colonization among the NB was 47% (181/382), that of MSSA
was 39% (147 NB), and that of MRSA was 9% (34 NB).
For newborn patients, the best body site for surveillance culture of
S. aureus was the umbilical stump, as can be seen in Table 3. We
evaluated the positivity of the combination of body sites. The best
combination to detect S. aureus in NB was the anterior nares plus the
umbilical stump, increasing the positivity to 86% for MSSA and 91%
for MRSA.Table 3
Proportion of positive patients (pregnant women and newborns) who would have been de
methicillin-susceptible (MSSA) and methicillin-resistant S. aureus (MRSA) at the Hospital d
Colonized pregnant women (n = 216)
Body site MSSA (n = 191) MRSA (n = 15)
Nares 59% 67%
Anus 25% 20%
Perineum 24% 20%
Oropharynx 52% 47%
Nares and anus 73% 80%
Nares and perineum 73% 80%
Nares and oropharynx 83% 80%
Anus and perineum 39% 40%
Anus and oropharynx 69% 53%
Perineum and oropharynx 68% 60%Among pregnant women, the best body site was the anterior nares
(Table 3). The best combination was the anterior nares plus
the oropharynx, increasing the positivity to 83% for MSSA and 80%
for MRSA.
Exclusive oropharynx colonization was observed in 17% of
pregnant women colonized by MSSA and 7% by MRSA, while it
occurred in 4% of NB colonized by MSSA and 6% by MRSA.
Tables 4 and 5 show the evaluation of factors associated with nasal
colonization when compared with extranasal colonization in preg-
nant women and NB, respectively.
Because of the high proportion of cesarian section deliveries in our
study, we evaluated whether delivery by caesarian section was
associated with colonization of NB in mothers who were colonized by
S. aureus. We found no statistical association for MSSA (relative risk
[RR] 1.00; 95% conﬁdence interval [CI] 0.70–1.45; P = 0.98) or MRSA
(RR 1.29; 95% CI 0.42–4.00; P = 0.63).
Maternal underlying diseases were analyzed individually, but
nonewas statistically signiﬁcant. Antimicrobial drugs used by patients
during hospitalization were also evaluated individually but were not
statistically signiﬁcant.
Among the positive NB, when comparing MSSA and MRSA the age
at ﬁrst culture was 3.7 days (SD 2.9) and 3.4 days (SD 1.2),
respectively. There was no statistical difference (P = 0.54).
4. Discussion
Many authors advocate the use of surveillance cultures to identify
S. aureus asymptomatic carriers, especially MRSA. It is generally
considered that it is sufﬁcient to culture the anterior nares (Andrews
et al., 2009; Byrnes et al., 2010; Mertz et al., 2007; Mertz et al., 2009;
Volk et al., 2011); however, our study demonstrates that cultures of
only this body site can be misleading. Even the combination of
cultures at 2 body sites (positivity of 80–90%) presented relatively
poor performance in identifying carriers.
Studies have deﬁned that cultures of the oropharynx are important
to identify carriers that have negative nasal cultures (Marshall and
Spelman, 2007; Nilson and Ripa, 2006). However, in our study,
oropharynx as the only positive body site occurred in 17% of pregnant
women with MSSA and in 7% of those with MRSA. The same occurred
for NB, and less than 6% of carriers had the oropharynx as their only
positive site.
Surveillance cultures for S. aureus are used for 3 purposes: to
identify patients colonized by S. aureus, usually MRSA, and put them
under isolation precautions; to identify colonized patients and
decolonize them (these 2 purposes are in order to prevent the
pathogen, usually MRSA, from spreading in the hospital); and to
identify and decolonize patients who will be submitted to invasive
procedures in order to prevent infection related to the procedure.
Our study shows that it may be necessary to culture various body
sites to identify all asymptomatic carriers and this may be expensivetected by surveillance cultures from different body sites (alone or in combination) for
as Clínicas, University of São Paulo, Brazil (February 2009–January 2010).
Colonized newborns (n = 181)
Body site MSSA (n = 147) MRSA (n = 34)
Nares 59% 50%
Umbilical 64% 68%
Perineum 54% 68%
Oropharynx 44% 38%
Nares and umbilical 86% 91%
Nares and perineum 83% 85%
Nares and oropharynx 71% 65%
Umbilical and perineum 77% 76%
Umbilical and oropharynx 77% 79%
Perineum and oropharynx 73% 79%
Table 4
Evaluation of potential factors associated with nasal carriage of MSSA and MRSA in colonized pregnant women at the Hospital das Clínicas, University of São Paulo, Brazil (February
2009–January 2010).
MSSA carriers (n = 191) MRSA carriers (n = 15)
Nasal (n=112) Only extra nasal (n=79) RR (95% CI) P Nasal (n=10) Only extra nasal (n=5) RR (95% CI) P
Age (years), mean (SD) 29.9 (6.6)a 29.8 (7.1) 0.93 29.2 (5.9) 28.8 (5.8) 0.89
Number of pregnancies, mean (SD) 2.7 (1.6) 2.6 (1.4) 0.71 2.1 (1.0) 2.4 (1.5) 0.65
Number of previous deliveries,
mean (SD)
1.2 (1.2) 1.3 (1.3) 0.76 1.1 (1.0) 1.2 (1.6) 0.88
Number of people in household,
mean (SD)
3.2 (1.4)b 3.2 (1.3) 0.86 2.2 (0.6) 3.6 (1.8) 0.04
Days from admission until delivery,
mean (SD)
2.9 (6.8) 3.2 (7.0) 0.72 2.4 (7.2) 2.8 (6.3) 0.92
Delivery by cesarean section 80 (71%)a 61 (77%)c 0.86 (0.67–1.11) 0.27 7 (78%)a 4 (80%) 0.95 (0.38–2.39) 1.00
Prenatal follow-up at our hospital 96 (86%) 66 (84%) 1.07 (0.76–1.53) 0.68 8 (80%) 4 (80%) 1.00 (0.41–2.45) 1.00
Underlying conditions
Comorbidities 84 (75%) 61 (77%) 0.95 (0.73–1.25) 0.72 8 (80%) 5 (100%) 0.62 (0.40–0.95) 0.43
UTI treated during pregnancy 32 (29%) 22 (28%) 1.01 (0.78–1.32) 0.91 3 (30%) 1 (20%) 1.18 (0.57–2.42) 0.59
Smoker 24 (21%) 17 (22%) 1.00 (0.75–1.33) 0.99 1 (10%) 1 (20%) 0.72 (0.17–3.03) 0.57
Smoked during pregnancy 8 (7%) 7 (9%) 0.90 (0.55–1.47) 0.66 1 (10%) 1 (20%) 0.72 (0.17–3.03) 0.57
Surgery during last year 14 (13%) 6 (8%) 1.22 (0.89–1.67) 0.26 2 (20%) 1 (20%) 1.00 (0.41–2.45) 0.74
Use of medication during pregnancy
Antimicrobial drug 37 (33%) 25 (32%) 1.03 (0.80–1.32) 0.84 3 (30%) 2 (40%) 0.86 (0.38–1.95) 0.57
Corticosteroids 8 (7%) 5 (6%) 1.05 (0.67–1.65) 0.83 0 0
RR = Relative risk; CI = conﬁdence interval; UTI = urinary tract infection.
a Data not available for 1 patient.
b Data not available for 4 patients.
c Data not available for 3 patients.
Table 5
Evaluation of potential factors associated with nasal carriage of MSSA and MRSA in colonized neonates at the Hospital das Clínicas, University of São Paulo, Brazil (February 2009–
January 2010).
MSSA carriers (n = 147) MRSA carriers (n = 34)
Nasal (n = 87) Only extra nasal (n = 60) RR (95% CI) P Nasal (n = 17) Only extra nasal (n = 17) RR (95% CI) P
Male sex 40 (46%) 26 (43%) 1.04 (0.80–1.37) 0.75 11 (65%) 9 (53%) 1.28 (0.62–2.64) 0.049
Birth weight
b1000 g 1 (1%) 2 (3%) 0.50 0 0
1001 to 1500g 5 (6%) 3 (5%) 0 0
1501 to 2500 g 0 1 (2%) 1 (6%) 1 (6%) 1.00
N2501 g 81 (93%) 54 (90%) 16 (94%) 16 (94%)
Gestational age
b37 weeks 11 (13%) 9 (15%) 0.44 4 (24%) 3 (18%) 1.00
37 to 41 weeks 76 (87%) 50 (83%) 13 (76%) 14 (82%)
N42 weeks 0 1 (2%) 0 0
Duration of membrane
rupture (h), mean (SD)
5.6 (27.3)a 2.4 (4.2) 0.37 1.1 (3.2) 4.1 (11.5) 0.30
Number of vaginal touches
during labor, mean (SD)
2.4 (3.2) 2.4 (2.5) 0.99 1.5 (2.3) 1.9 (2.0) 0.63
Delivery by cesarean section 62 (71%) 41 (68%) 1.06 (0.78–1.43) 0.70 15 (88%) 14 (81%) 1.29 (0.42–4.00) 1.00
Nutrition with maternal milk 82 (94%) 53 (88%) 1.46 (0.74–2.89) 0.16 16 (94%) 16 (94%) 1.00 (0.24–4.17) 1.00
Use of invasive procedures during hospitalization
Peripheral venous catheter 8 (9%) 5 (9%) 1.04 (0.66–1.64) 0.86 2 (12%) 1 (6%) 1.38 (0.57–3.32) 1.00
Parenteral nutrition 6 (7%) 7 (12%) 0.82 (0.45–1.50) 0.48 1 (6%) 0 2.06 (1.45–2.93) 1.00
Central venous catheter 3 (3%) 7 (12%) 0.49 (0.19–1.27) 0.09 0 1 (6%) 1.00
Noninvasive ventilation 2 (2%) 4 (7%) 0.55 (0.18–1.73) 0.23 0 0
Mechanical ventilation 1 (1%) 3 (5%) 0.42 (0.08–2.28) 0.30 0 1 (6%) 1.00
Use of antimicrobial drugs 1 (1%) 7 (12%) 0.20 (0.03–1.27) 0.01 1 (6%) 1 (6%) 1.00 (0.24–4.17) 1.00
Age at ﬁrst positive
culture (days), mean (SD)
3.3 (0.8) 4.2 (3.8) 0.09 3.5 (1.3) 3.2 (1.0) 0.56
Discharged on third day 76 (87%) 45 (75%) 1.48 (0.93–2.37) 0.05 13 (76%) 14 (76%) 0.84 (0.40–1.79) 1.00
Conditions pertaining to the mother
Underlying diseases 64 (73%) 46 (78%) 0.94 (0.70–1.26) 0.67 15 (88%) 9 (53%) 3.13 (0.87–11.21) 0.02
Use of antimicrobial drugs 23 (26%) 16 (27%)a 0.99 (0.73–1.34) 0.93 6 (35%) 3 (18%) 1.52 (0.80–2.87) 0.44
Smoking 9 (10%) 5 (9%) 1.10 (0.72–1.66) 0.68 2 (12%) 1 (6%) 1.38 (0.57–3.32) 1.00
Use of corticosteroids 5 (6%) 7 (12%) 0.69 (0.35–1.36) 0.16 1 (6%) 0 2.06 (1.45–2.93) 1.00
Gestational diabetes mellitus 8 (9%) 7 (12%) 0.89 (0.54–1.46) 0.63 3 (18%) 3 (18%) 1.00 (0.41–2.42) 1.00
Diabetes mellitus
(not gestational)
8 (9%) 1 (2%) 1.55 (1.18–2.04) 0.08 1 (6%) 1 (6%) 1.00 (0.24–4.17) 1.00
Chronic hypertension 16 (18%) 15 (25%) 0.84 (0.58–1.22) 0.33 4 (24%) 3 (18%) 1.19 (0.56–2.52) 1.00
Gestational hypertension 17 (19%) 10 (17%) 1.08 (0.78–1.50) 0.66 1 (6%) 1 (6%) 1.00 (0.24–4.17) 1.00
Maternal colonization
by S. aureus
56 (64%)a 35 (58%) 1.24 (0.59–2.59) 0.54 9 (53%) 7 (41%) 1.27 (0.65–2.48) 0.49
a Data not available for 1 patient.
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European countries, cultures have been used to identify carriers and
to direct decolonization in order to prevent transmission of S. aureus,
especially MRSA in hospitals (Holzknecht et al., 2010). This strategy is
called “search and destroy” and is widely used in Dutch hospitals
where it is held responsible for the low incidence of MRSA (Vos et al.,
2009). This strategy has been used in households of colonized patients
and healthcare workers (HCW) and includes even their pets (Böcher
et al., 2010). More recently, this strategy has been reported to be
useful in controlling a MRSA clone in a community in Denmark
(Bartels et al., 2010), although the appearance of community MRSA is
a challenge to nosocomial control as the community may be an
important and continuous source of MRSA for the hospital (Holz-
knecht et al., 2010).
Colonization pressure has been suggested as a risk factor for a
patient to acquire an infection or to become colonized when
hospitalized in a hospital unit (Pacheco et al., 2011). Identifying and
colonizing asymptomatic carriers may be a strategy to decrease
colonization pressure.
It is generally accepted that asymptomatic colonization by S. aureus
is common and is a prerequisite for the development of staphylococcal
infection. The risk of infection in nasal carriers is estimated to be 2–12
times higher than in noncolonized persons (Simor, 2011). The absence
of MRSA colonization in intensive care patients has been reported to
rule out this microorganism as the etiology in the event of ventilator-
associated pneumonia (Chan et al., 2012). This is the rationale behind
eradicating the carriage of S. aureus (decolonization) in patients at risk
for infection. Although there are studies with conﬂicting results,
protocols of nasal decolonization have been shown to be efﬁcient in
reducing S. aureus infections in dialysis and in patients submitted to
surgical procedures. In the case of extranasal carriage, there are no
well-deﬁned protocols for decolonization and results have not been
well evaluated (Simor, 2011; Wertheim et al., 2004).
In our study, we collected cultures from 4 different body sites but
still cannot be sure to have identiﬁed all asymptomatic S. aureus
carriers. It is possible that culturing other sites, such as the hands,
would have led to the identiﬁcation of carriers in an even larger
proportion of patients. However, the hands usually carry transient
microbiota and it was our objective to evaluate a more permanent
carriage of S. aureus. The “search and destroy” strategy usually does
not rely on nasal cultures only and can include the throat, perineum,
nonintact skin, urine (in the case of urinary catheter use), drain ﬂuid
(in the case of drain use), and/or exit sites (in the case of drain and/or
catheter use) of patients. HCW can have cultures taken from the nose,
throat, and skin lesions, if present (Vos et al., 2009). Our study clearly
conﬁrms the need for multiple culture sites to ensure sensitivity.
Because of the difﬁculties described, we tried to determine the
factors associated with nasal carriage of S. aureus that could suggest a
higher efﬁcacy in identifying carriers using only the culture of the
anterior nares. Unfortunately, we found no signiﬁcant or useful factors
in pregnant women or in NB. The MRSA nasally colonized women
lived in less populated households when compared with women
with exclusive extranasal colonization (P = 0.04). This is difﬁcult to
explain and probably has limited clinical usefulness. Thuswe found no
factors that may indicate which patients are more prone to
colonization at the anterior nares and which should be cultured at
other body sites.
One of the points that require discussion is the use of conventional
cultures when there are other surveillance methods available.
Surveillance using PCR is considered to be a quicker method but
may generate false-positive results (van Hal et al., 2007). Another
option may be the use of chromogenic media; however, these have
been evaluated only for nasal swabs (Wolk et al., 2009).
It is unusual to investigate colonization by MSSA; however, our
study showed a high prevalence of colonization by MSSA in our
hospital. We decided to analyze the data obtained in order to evaluatethis pathogen's behavior and its risk factors for colonization. It is
known that MSSA can cause infection with the same severity and
mortality as MRSA. MSSA has no beta-lactam resistance but can be
resistant to other classes of drugs and harbor different virulence genes
(Layer et al., 2006).
In our study, we considered that NB who presented a positive
culture only at birth were not colonized and determined that this
positive result should be considered as a culture contamination.
However, this is controversial. There are currently no deﬁned
protocols in which a newborn can be considered colonized and it is
believed that colonization by Gram-positive bacteria occurs very early
in life (Brauncajs et al., 2009). It is possible that a positive culture at
birth may represent early and transient colonization.
Although the prevalence of S. aureus between pregnant women
was high, the prevalence of patients colonized by both MSSA and
MRSAwas very low (2%). This may have been observed because of the
use of enrichment broth in which 1 lineage may predominate.
Finally, the results involve only a subset of patients, pregnant
women and NB, and thus may not be applicable to other patient
populations. Although the prevalence of S. aureus was very high, the
prevalence of MRSA carriers was relatively low among pregnant
women, limiting somewhat the evaluation of risk factors. This is
probably due to the fact that, in Brazil, compared with the USA,
MRSA is not as widespread in the community (Mia et al., 2012; Moran
et al., 2006).
In conclusion, our study involving pregnant women and their NB
clearly conﬁrms the need for multiple culture sites to ensure
sensitivity. There seem to be no features that distinguish nasal
carriers from people who are only colonized at extranasal sites. Thus
control programs that rely mainly on identifying carriers by
surveillance cultures may be seriously compromised.Acknowledgment
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